our mission

To develop and commercialize self-administered parenteral medicines that optimize clinical benefits with enhanced cost effective health outcomes

news / press releases

  • 18 November 2014

    Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer
  • 6 November 2014

    Antares Pharma Reports Third Quarter 2014 Operating and Financial Results
  • 3 November 2014

    Antares Pharma Announces Last Patient Enrolled in Phase 3 Quickshot Study Evaluating Testosterone-Deficient Adult Males
  • 30 October 2014

    Antares Pharma to Host Third Quarter 2014 Operating and Financial Results Conference Call
  • 15 September 2014

    Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer
  • 3 September 2014

    Antares Pharma to Present at the Morgan Stanley Healthcare Conference

latest products & technology


Otrexup (methotrexate) injection for subcutaneous use only.

Learn More >>